Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Substance Use Disorder (SUD): early-phase trial registry
15 of 16 indexed Substance Use Disorder (SUD) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,060 of 28,707 conditions by registered trial count.
16 US clinical trials · 15 currently recruiting · #1,060 of 28,707 conditions by registered trial count
Substance Use Disorder (SUD): 16 US clinical trials tracked, 15 recruiting.
Substance Use Disorder (SUD) is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 15 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Francisco, running 3 of these trials.
Enrollment posture brief
Registry condition substance-use-disorder-sud
OPEN 15 | RECR 94% | LATE 1 | EARLY 2 | RANK #1060 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Pancreatic Ductal Adenocarcinoma (PDAC) (94% recruiting · 17 trials)
Substance Use Disorder (SUD) lists 15 open slots (94% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Substance Use Disorder (SUD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Substance Use Disorder (SUD) is recruiting above its size-band peers.
15 of 16 indexed trials (93.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Substance Use Disorder (SUD) research.
University of California, San Francisco accounts for 3 of 16 trials (18.8%). 14 distinct sponsors appear on at least one study for this condition label.
-
Typical Substance Use Disorder (SUD) enrolment sits around 100 participants.
Median target enrolment is 100 among the 16 trials that report a genuine target (sentinel values excluded). 8 of those (50%) plan for fewer than 100 participants.
-
Substance Use Disorder (SUD) research is mostly interventional.
16 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
16 total, page 1 of 1
Pathways to Perinatal Mental Health Equity
University of Massachusetts, Worcester
NCT06790641
Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons
University of Arkansas
NCT06923423
Calls and Coordination for Transitions of Care at Re-entry
University of Wisconsin, Madison
NCT06794983
California MEPS Hub
University of California, Los Angeles
NCT07433985
The Trans-Led Care Study
Illinois Institute of Technology
NCT06880705
Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
Icahn School of Medicine at Mount Sinai
NCT07318480
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
Massachusetts General Hospital
NCT07199335
Adolescent Stress and Substance Intervention Subsequent to Trauma
Rhode Island Hospital
NCT07197476
Open-Label Psilocybin Study in Transdiagnostic Population
Yale University
NCT06442423
WORTH Paths Intervention
Fairleigh Dickinson University
NCT06889831
Wellness, Intervention Strategies and HIV Care
University of California, San Francisco
NCT07069374
Substance Use in Pregnant People - Optimizing Retention in Treatment
Washington University School of Medicine
NCT07104123
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
University of California, San Francisco
NCT06678672
Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.
Medical College of Wisconsin
NCT06617949
Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder
University of California, San Francisco
NCT07214467
Addressing Barriers to Care for Substance Use Disorder Trial
Kaiser Permanente
NCT06729957
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Substance Use Disorder (SUD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Substance Use Disorder (SUD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Substance Use Disorder (SUD) page
16 registered trials, 15 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 15 Substance Use Disorder (SUD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, San Francisco sponsors the most Substance Use Disorder (SUD) trials on record, review their full trial history before evaluating a specific study. See University of California, San Francisco's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Substance Use Disorder (SUD) condition card totals 16 registered trials; most-linked intervention Care Navigation; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.